Urologic Pharmacology, An Issue of Urologic Clinics
- 1st Edition, Volume 49-2 - April 21, 2022
- Latest edition
- Editor: Craig V. Comiter
- Language: English
In this issue of Urologic Clinics of North America, guest editor Dr. Craig V. Comiter brings his considerable expertise to the topic of Urologic Pharmacology. Medical therapies… Read more
Purchase options
In this issue of Urologic Clinics of North America, guest editor Dr. Craig V. Comiter brings his considerable expertise to the topic of Urologic Pharmacology. Medical therapies for benign prostatic hyperplasia, erectile dysfunction, hypogonadism, overactive bladder, and prostate cancer are widely available, and a basic understanding of the pharmacology of existing treatment options are necessary to avoid complications and maximize efficacy associated with patient outcomes. In this issue, top experts in the field provide current clinical information to help urologists effectively and quickly treat patients.
-
Contains 14 relevant, practice-oriented topics including medical treatment for benign prostatic hyperplasia, medical treatment for urinary tract infections, nutraceuticals and phytotherapy in men’s health, hormonal therapy for prostate cancer, medical treatment of female sexual dysfunction, and more.
-
Provides in-depth clinical reviews on urologic pharmacology, offering actionable insights for clinical practice.
-
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
Medical Treatment of Hypogonadism in Men
Pharmacotherapy for Erectile Dysfunction in 2021 and Beyond
Medical Treatment of Disorders of Ejaculation
Medical Treatment of Benign Prostatic Hyperplasia
Nutraceuticals and Phytotherapy in Men’s Health: Antioxidants, Pro-oxidants, and a Novel Opportunity for Lifestyle Changes
Medical Treatment of Overactive Bladder
Chemodenervation in Urology
Pharmacologic Management of Interstitial Cystitis/Bladder Pain Syndrome
Medical Treatment for Urinary Tract Infections
Medical Treatment of Female Sexual Dysfunction
Hormone Treatment of Prostate Cancer:: Evidence for Usage and Safety
Immunotherapy and Checkpoint Inhibitors in Urologic Cancer
Medical Treatment and Prevention of Urinary Stone Disease
Immunosuppression Therapy in Kidney Transplantation
Pharmacotherapy for Erectile Dysfunction in 2021 and Beyond
Medical Treatment of Disorders of Ejaculation
Medical Treatment of Benign Prostatic Hyperplasia
Nutraceuticals and Phytotherapy in Men’s Health: Antioxidants, Pro-oxidants, and a Novel Opportunity for Lifestyle Changes
Medical Treatment of Overactive Bladder
Chemodenervation in Urology
Pharmacologic Management of Interstitial Cystitis/Bladder Pain Syndrome
Medical Treatment for Urinary Tract Infections
Medical Treatment of Female Sexual Dysfunction
Hormone Treatment of Prostate Cancer:: Evidence for Usage and Safety
Immunotherapy and Checkpoint Inhibitors in Urologic Cancer
Medical Treatment and Prevention of Urinary Stone Disease
Immunosuppression Therapy in Kidney Transplantation
- Edition: 1
- Latest edition
- Volume: 49-2
- Published: April 21, 2022
- Language: English
CC
Craig V. Comiter
Affiliations and expertise
Associate Professor, Department of Urology, Stanford University Medical Center, Stanford, CA